Imed Infinity Medical LP (XTAE:IMED) Return-on-Tangible-Asset: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:IMED Imed Infinity Medical LP XTAE:IMED
18 GF Score
Price ₪0.89
! 2 Warning Signs
View Full Analysis

What is Imed Infinity Medical LP Return-on-Tangible-Asset?

Imed Infinity Medical LP XTAE:IMED 18 Return-on-Tangible-Asset is 0.00% as of . 20. GuruFocus rates XTAE:IMED with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 685 Healthcare Providers & Services companies, Imed Infinity Medical LP ranks worse than 145985.26% on this metric.

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Imed Infinity Medical LP's annualized Net Income for the quarter that ended in . 20 was ₪ Mil. Imed Infinity Medical LP's average total tangible assets for the quarter that ended in . 20 was ₪ Mil. Therefore, Imed Infinity Medical LP's annualized Return-on-Tangible-Asset for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Imed Infinity Medical LP's Return-on-Tangible-Asset or its related term are showing as below:

XTAE:IMED's Return-on-Tangible-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.51
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Imed Infinity Medical LP  (XTAE:IMED) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Imed Infinity Medical LP Return-on-Tangible-Asset Related Terms


Imed Infinity Medical LP Return-on-Tangible-Asset Historical Data

* Premium members only.

The historical data trend for Imed Infinity Medical LP's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imed Infinity Medical LP Return-on-Tangible-Asset Chart

Imed Infinity Medical LP Annual Data
Trend
Return-on-Tangible-Asset

Imed Infinity Medical LP Semi-Annual Data
Return-on-Tangible-Asset

XTAE:IMED vs VEEV, BTSG, HQY: Return-on-Tangible-Asset Comparison

For the Health Information Services subindustry, Imed Infinity Medical LP's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imed Infinity Medical LP Return-on-Tangible-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Imed Infinity Medical LP's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Imed Infinity Medical LP's Return-on-Tangible-Asset falls into.


XTAE:IMED
18GF Score
Imed Infinity Medical LP XTAE:IMED
Return-on-Tangible-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imed Infinity Medical LP Return-on-Tangible-Asset Calculation

Imed Infinity Medical LP's annualized Return-on-Tangible-Asset for the fiscal year that ended in . 20 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=/( (+)/ )
=/
= %

Imed Infinity Medical LP's annualized Return-on-Tangible-Asset for the quarter that ended in . 20 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (. 20) net income data.

What does a Return-on-Tangible-Asset of 0.00% mean?
Imed Infinity Medical LP (XTAE:IMED) has a Return-on-Tangible-Asset of 0.00% as of . 20. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Imed Infinity Medical LP and its competitors. According to the industry distribution chart, Imed Infinity Medical LP ranks #999999 out of 685 companies in the Healthcare Providers & Services industry.
Is Imed Infinity Medical LP's Return-on-Tangible-Asset too high?
Imed Infinity Medical LP's current Return-on-Tangible-Asset is 0.00%. Based on the distribution chart, Imed Infinity Medical LP ranks #999999 out of 685 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Imed Infinity Medical LP has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Imed Infinity Medical LP's Return-on-Tangible-Asset compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Imed Infinity Medical LP ranks #999999 out of 685 companies for Return-on-Tangible-Asset. This places Imed Infinity Medical LP in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Imed Infinity Medical LP and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imed Infinity Medical LP's current Return-on-Tangible-Asset is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imed Infinity Medical LP stock overvalued right now?
Imed Infinity Medical LP (XTAE:IMED) has a current Return-on-Tangible-Asset of 0.00%. The current Return-on-Tangible-Asset is 0.00%. Imed Infinity Medical LP's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Imed Infinity Medical LP (XTAE:IMED), the current Return-on-Tangible-Asset is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imed Infinity Medical LP Business Description

Address Azrieli Center, Menachem Begin 132, Triangle Tower 42th Floor, Tel Aviv, ISR, 6701101
Imed Infinity Medical LP is engaged in the business of investing in digital health businesses.
18GF Score

Get the complete analysis for XTAE:IMED

Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.89
Price